Page last updated: 2024-11-03

procarbazine and Conus Medullaris Syndrome

procarbazine has been researched along with Conus Medullaris Syndrome in 1 studies

Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.

Research Excerpts

ExcerptRelevanceReference
"Spinal cord compression has been reported in 5% of patients with solid tumors."1.29[Spinal cord compression as the presenting form of non-Hodgkin's lymphoma]. ( Amigo, ML; Caballero, D; del Cañizo, C; Revilla, R; San Miguel, JF; Sánchez, C, 1995)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amigo, ML1
Revilla, R1
Sánchez, C1
del Cañizo, C1
Caballero, D1
San Miguel, JF1

Other Studies

1 other study available for procarbazine and Conus Medullaris Syndrome

ArticleYear
[Spinal cord compression as the presenting form of non-Hodgkin's lymphoma].
    Sangre, 1995, Volume: 40, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorub

1995